Business
Vanda Pharmaceuticals Announces Participation at the Jefferies 2019 Global Healthcare Conference
WASHINGTON, May 31, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) announced today that Mihael H. Polymeropoulos, co-founder and Chief
About this update from Vanda Pharmaceuticals Inc.
[{"type":"text","content":"WASHINGTON, May 31, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) announced today that Mihael H. Polymeropoulos, co-founder and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference in New York City on Tuesday, June 4, 2019. A corporate presentation is scheduled for 11:00 a.m. Eastern Time.\nThe corporate presentation given at the Jefferies 2019 Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.\nAbout Vanda Pharmaceuticals Inc.\nVanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.\nCompany Contact:Jim KellyExecutive Vice President and Chief Financial OfficerVanda Pharmaceuticals Inc.(202) [email protected]\n View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-jefferies-2019-global-healthcare-conference-300859795.html\nSOURCE Vanda Pharmaceuticals Inc.\n\n ","length":2676,"tagName":"div"}]